Identifying a New Type of ER-Negative Breast Cancer
Author Information
Author(s): Chin Suet F, Teschendorff Andrew E, Marioni John C, Wang Yanzhong, Barbosa-Morais Nuno L, Thorne Natalie P, Costa Jose L, Pinder Sarah E, van de Wiel Mark A, Green Andrew R, Ellis Ian O, Porter Peggy L, Tavaré Simon, Brenton James D, Ylstra Bauke, Caldas Carlos
Primary Institution: Cancer Research UK Cambridge Research Institute and Department of Oncology University of Cambridge
Hypothesis
Can high-resolution aCGH and expression profiling identify distinct genomic subtypes of ER-negative breast cancer?
Conclusion
The study provides strong evidence for a novel subtype of high-grade ER-negative tumors characterized by low genomic instability and identifies genomic regions associated with poor prognosis.
Supporting Evidence
- The study identified a novel subtype of high-grade ER-negative breast cancer.
- Amplification of specific genomic regions was associated with significantly worse prognosis.
- Validation of the genomic subtype was achieved in an external breast cancer cohort.
- High-resolution profiling revealed common copy number alterations linked to poor outcomes.
- Significant associations were found between genomic alterations and aberrant gene expression.
Takeaway
Researchers found a new type of breast cancer that doesn't have a lot of genetic changes, which could help doctors understand and treat it better.
Methodology
The study used high-resolution oligo-array-based aCGH to analyze copy number alterations in 171 primary breast tumors and matched expression data.
Limitations
The study's findings may not be generalizable to larger tumors or those from heavily treated populations.
Participant Demographics
The cohort consisted of primary operable invasive breast carcinomas collected from 1990 to 1996, with a focus on smaller tumors and lower Nottingham Prognostic Index.
Statistical Information
P-Value
0.003
Confidence Interval
HR = 2.3 (1.3-4.4)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website